Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX2G3C
|
||||
| Drug Name |
Dimethyl-(11-methyl-2,3,3a,8-tetrahydro-1-oxa-12b-aza-dibenzo[e,h]azulen-2-ylmethyl)-amine
|
||||
| Synonyms |
CHEMBL85735
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H24N2O
|
||||
| Canonical SMILES |
CN(C)CC1CC2N(O1)c3cc(C)ccc3Cc4ccccc24
|
||||
| InChI |
InChI=1S/C20H24N2O/c1-14-8-9-16-11-15-6-4-5-7-18(15)20-12-17(13-21(2)3)23-22(20)19(16)10-14/h4-10,17,20H,11-13H2,1-3H3
|
||||
| InChIKey |
IEMJYQZKJFERDW-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
| Histamine H1 receptor | Target Info | [1587926] | |||
| PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.